Elevance Health Inc.
ELVNYSEHealthcare● Active
$418.15
+$2.62(+0.63%)
Market Cap$90.8B
P/E Ratio—
52W High$421
52W Low$273.71
Elevance Health Inc.（ELV）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ELV · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | $5.66B | $5.97B | $5.99B | $6.02B | $6.09B |
| Depreciation & Amort. | $1.55B | $1.39B | $1.75B | $1.68B | $1.30B |
| Stock-Based Comp. | $0.28B | $0.19B | $0.29B | $0.26B | $0.26B |
| Change in Working Capital | ($3.28B) | ($1.72B) | ($0.54B) | $0.25B | $0.78B |
| Net Cash from Operations | $4.29B | $5.81B | $8.06B | $8.40B | $8.36B |
| Investing Activities | |||||
| Capital Expenditure | ($1.12B) | ($1.26B) | ($1.30B) | ($1.15B) | ($1.09B) |
| Purchases of Investments | ($15.03B) | ($17.99B) | ($16.24B) | ($24.95B) | ($18.67B) |
| Sales of Investments | $15.10B | $18.57B | $13.54B | $22.61B | $14.61B |
| Net Cash from Investing | ($1.34B) | ($5.17B) | ($5.57B) | ($4.56B) | ($9.64B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($2.60B) | ($2.90B) | ($2.68B) | ($2.32B) | ($1.90B) |
| Dividends Paid | ($1.53B) | ($1.51B) | ($1.40B) | ($1.23B) | ($1.10B) |
| Debt Issued / Repaid | $2.33B | $5.56B | $0.74B | $1.79B | $2.34B |
| Net Cash from Financing | ($1.74B) | $1.19B | ($3.35B) | ($1.32B) | $0.42B |
| Free Cash Flow | |||||
| Free Cash Flow | $3.17B | $4.55B | $6.76B | $7.25B | $7.28B |
| FCF Margin %(computed) | 1.59% | 2.57% | 3.95% | 4.63% | 5.25% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Elevance Health Inc.
关于Elevance Health Inc.（ELV）现金流量表
Elevance Health Inc. 2025财年经营活动现金流$4.29B，自由现金流$3.17B（FCF利润率1.59%），资本支出($1.12B)。
常见问题
ELV · 4 问Elevance Health Inc. 2025财年自由现金流$3.17B，同比down30.3%。
ELV free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10